Tramadol and Seizure Risk
Yes, seizures have been definitively reported with tramadol use, and this is a well-established adverse effect that occurs even within recommended dosage ranges. The FDA has issued a black box warning specifically highlighting this risk. 1
FDA-Documented Seizure Risk
The FDA drug label explicitly warns that:
- Seizures have been reported in patients receiving tramadol within the recommended dosage range 1
- Seizure risk increases with doses above the recommended range 1
- The risk is further elevated when tramadol is combined with medications that lower seizure threshold, including SSRIs, SNRIs, tricyclic antidepressants, MAO inhibitors, other opioids, and neuroleptics 1
- In overdose situations, naloxone administration may paradoxically increase seizure risk 1
Clinical Practice Guidelines on Seizure Risk
Multiple clinical guidelines acknowledge tramadol's seizure-inducing properties:
- The 2024 World Society of Emergency Surgery guidelines state that tramadol may reduce the seizure threshold and is contraindicated in patients with a history of seizures 2
- The 2018 ESMO cancer pain guidelines note that tramadol can lower seizure thresholds, particularly in elderly patients 2
- The American Geriatrics Society recognizes that seizure risk increases with high doses or in predisposed patients 3
Clinical Evidence from Real-World Practice
Research studies have documented the occurrence and characteristics of tramadol-induced seizures:
- A 2009 cross-sectional study of 132 tramadol users found that 46.2% experienced seizures within 24 hours of tramadol ingestion, with all documented cases showing generalized tonic-clonic seizures 4
- Importantly, this study found no dose-dependent relationship - seizures occurred across all dose ranges, with the most common dose range being 500-1000 mg 4
- A 2019 Iranian study reported a 58% seizure prevalence among tramadol-intoxicated patients presenting to the emergency department 5
- A 2012 study found that 89% of tramadol-related seizures occurred within the first 24 hours of intake, with higher risk in patients concomitantly using alcohol, illicit drugs, antipsychotics, or antidepressants 6
High-Risk Populations and Scenarios
Patients at particularly elevated risk include:
- Those with a history of seizures (3.7-fold increased risk) 5
- Patients taking serotonergic medications (SSRIs, SNRIs, TCAs, MAOIs) due to additive effects 1, 2
- Individuals with epilepsy, head trauma, metabolic disorders, or undergoing alcohol/drug withdrawal 1
- Elderly patients, who are more vulnerable to CNS effects 2
Important Clinical Caveats
- The seizure risk is NOT strictly dose-dependent - seizures can occur even at therapeutic doses 4
- The combination of tramadol with serotonergic agents creates a dual risk: both seizures and potentially fatal serotonin syndrome 1, 2
- EEG abnormalities may be present acutely but often normalize within one week 6
- Most seizures are generalized tonic-clonic in nature 4, 6